Spectrum Pharmaceuticals/ US84763A1088 /
2023-07-31 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1.03USD | - | 122,550 Turnover: 124,444.33 |
-Bid Size: - | -Ask Size: - | 211.42 mill.USD | - | - |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.41 USD | -59.80% |
EPS Diluted: | -0.41 USD | -59.80% |
Revenues per Share: | 0.05 USD | - |
Book Value per Share: | 0.14 USD | -49.40% |
Cash Flow per Share: | -0.47 USD | -29.96% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 10.11 USD | - |
Net Income: | -75.40 USD | -52.47% |
Operating Cash Flow: | -96.99 USD | - |
Cash and Cash Equivalents: | 40.37 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 20.91 | 7.48 |
P/BV ratio: | 7.58 | 2.71 |
P/CF Ratio: | -2.18 | -0.78 |
PEG: | 0.04 | - |
Earnings Yield: | -39.81% | -111.26% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 211.42 mill. USD | 75.65 mill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 205.26 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | -718.78% |
Net Profit Margin: | -745.51% |
Return on Equity: | -270.37% |
Return on Assets: | -72.97% |
Financial Strength
Liquidity I / Cash Ratio: | 94.57% |
Liquidity II / Quick Ratio: | 125.02% |
Liquidity III / Current Ratio: | 236.64% |
Debt / Equity Ratio: | 270.55% |
Dynam. Debt / Equity Ratio: | -77.79% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 2022-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |